OLVIG
RETA

Oliver Lagore Vanvalin Investment Group’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Oliver Lagore Vanvalin Investment Group’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-107
Closed -$4.07K – 742
2022
Q4 		$4.07K Buy
+107
New +$4.07K ﹤0.01% 491